SCHEMBL3255707

SCHEMBL3255707

O=C(O)Cc1n[nH]c2ncnc(O)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
GABRR1 P24046 1/20 0.37
AGBL2 Q5U5Z8 2/20 0.34
GABRP O00591 2/20 0.33
GABRD O14764 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB1 P18505 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRB2 P47870 2/20 0.33
GABRA4 P48169 2/20 0.33
GABRE P78334 2/20 0.33
GABRA6 Q16445 2/20 0.33
GABRG1 Q8N1C3 2/20 0.33
GABRG3 Q99928 2/20 0.33
GABRQ Q9UN88 2/20 0.33
NOTUM Q6P988 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3254955 0.84 LMNA (0.40) LMNAGABRR1AGBL2GABRPGABRD
SCHEMBL4923299 0.78
SCHEMBL4925835 0.75 HCAR2 (0.33)
SCHEMBL479506 0.71 LMNA (0.46) LMNAGABRR1AGBL2GABRPGABRD
SCHEMBL4922463 0.69
SCHEMBL4932404 0.68 SMN1; SMN2 (0.32)
SCHEMBL12590748 0.67 AKR1B1 (0.40) LMNAGABRR1GABRPGABRDGABRA1
SCHEMBL9918631 0.66 CCR4 (0.44) CYP1A2CYP2C19
SCHEMBL4930122 0.66 YTHDC1 (0.43) HSD17B10
SCHEMBL24262375 0.66 NOTUM (0.57) NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1232157-B1 NON-AGGREGATING, NON-QUENCHING OLIGOMERS COMPRISING NUCLEOTIDE ANALOGUES; METHODS OF SYNTHESIS AND USE THEREOF EPOCH BIOSCIENCES INC (US) 2010-05-05 EP disclosed
US-6660845-B1 Peptide nucleic acids in which one or more purine bases are substituted by a pyrazolo(5,4-d)pyrimidine or by a 7-deazapurine purine analogue; improved hybridization analysis EPOCH BIOSCIENCES, INC. 2003-12-09 US disclosed
EP-1232157-A2 NON-AGGREGATING, NON-QUENCHING OLIGOMERS COMPRISING NUCLEOTIDE ANALOGUES; METHODS OF SYNTHESIS AND USE THEREOF Epoch Biosciences, Inc. (US) 2002-08-21 EP disclosed
WO-2001038584-A2 NON-AGGREGATING, NON-QUENCHING OLIGOMERS COMPRISING NUCLEOTIDE ANALOGUES; METHODS OF SYNTHESIS AND USE THEREOF EPOCH BIOSCIENCES, INC. (US) 2001-05-31 WO disclosed